Anger Self-Management in Traumatic Brain Injury
ASMT
Anger Self-Management in Post-Acute Traumatic Brain Injury: Clinical Trial
2 other identifiers
interventional
90
1 country
3
Brief Summary
The present study addresses problematic anger and irritability in community dwelling persons with traumatic brain injury (TBI). It is designed to test the worth of a novel treatment approach called Anger Self-Management Training (ASMT), compared to a treatment offering supportive therapy focused on personal readjustment and education, the PRE (Personal Readjustment and Education). The project is a 3-center randomized controlled trial employing equivalent therapist time and therapeutic structure in the delivery of treatment options. The overall aim is to evaluate the relative response rate and correlates of treatment response for the ASMT as compared to the PRE.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Sep 2012
Longer than P75 for not_applicable
3 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 1, 2012
CompletedFirst Submitted
Initial submission to the registry
December 6, 2012
CompletedFirst Posted
Study publicly available on registry
December 10, 2012
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2016
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2016
CompletedResults Posted
Study results publicly available
October 19, 2018
CompletedOctober 19, 2018
October 1, 2018
3.8 years
December 6, 2012
May 14, 2018
October 18, 2018
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Post-Treatment Response Rate From Baseline on Anger Measures - Participant Report
Participant report only. The State-Trait Anger Expression Inventory-Revised Trait Anger Scale (STAXI-2 TA) measures how often angry feelings are experienced and the Anger Expression-Out (STAXI-2 AX-O) Scale addresses the expression of anger toward other persons or objects in the environment. The Brief Anger-Aggression Questionnaire (BAAQ) is a 6-item self-report scale that measures frequency of "acting-out" symptoms of anger. Overall treatment response is defined as ≥ 1 standard deviation change in the direction of improvement from pre- to 10 wk post-treatment on any 1 of the three anger scales used. Analysis first done by including participants who did not complete the assessment as non-responders (labeled as "missing outcomes included" or "MOI"). Analysis done a second time only using participants who completed the assessment (labeled as "missing outcomes removed" or "MOR").
Baseline, 10 weeks (post-treatment)
Study Arms (2)
Anger Self-Management Training (ASMT)
EXPERIMENTAL8-session, individual, psycho-educational intervention based on principles of self-monitoring and problem-solving training Significant other (friend or relative) invited to participate in 3 of 8 sessions
Personal Readjustment and Ed (PRE)
ACTIVE COMPARATOR8-session, individual, psycho-educational intervention based on principles of education and personal readjustment. Significant other (friend or relative) invited to participate in 3 of 8 sessions
Interventions
8-session, individual, psycho-educational intervention based on principles of self-monitoring and problem-solving training Significant other (friend or relative) invited to participate in 3 of 8 sessions
8-session, individual, psycho-educational intervention based on principles of education and personal readjustment to TBI Significant other (friend or relative) invited to participate in 3 of 8 sessions
Eligibility Criteria
You may qualify if:
- Age ≥ 16 at the time of injury
- ages 18 to 65 at the time of enrollment
- TBI (closed or penetrating) occurring a minimum of 6 months prior to enrollment
- TBI documented as complicated mild, moderate, or severe TBI by any one or more of the following indices:
- post-resuscitation score on Glasgow Coma Scale (GCS) \< 13 or GCS Motor \< 6;
- loss of consciousness, unresponsiveness or coma attributable to the TBI and persisting ≥ 1 hour;
- post-traumatic amnesia, or disorientation (O x 0, 1 or 2) attributable to the TBI and persisting ≥ 24 hours; or
- neuro-imaging study positive for TBI-related findings such as contusion, hematoma, hemorrhage, diffuse axonal injury, shear injury, and/ or depressed skull fracture
- Able to travel independently in the community (to maximize the probability that participants will be cognitively and physically able to engage in the treatment)
- Indication from self or other report that participant has problematic anger/ irritability that is new since the injury or worse than before the injury
- Self-report of anger ≥ 1 standard deviation above the mean for age and gender on the Trait Anger or Anger Expression-Out (AX-O) subscales of the State-Trait Anger Expression Inventory-2 (STAXI-2), or a score of ≥ 7 on the Brief Anger-Aggression Questionnaire (BAAQ)
- Able to speak and understand English sufficiently to complete the screening and outcome measures and to participate in a verbally based treatment program, which thus far exists only in English
- Informed consent given by participant or legally authorized representative.
You may not qualify if:
- History of schizophrenia or schizo-affective disorder, as documented in medical records or by self-report that a medical professional has given the diagnosis
- Current psychosis, major depression, or suicidal ideation; or history of manic or hypomanic episode as determined by the Mini-International Neuropsychiatric Interview for DSM-IV (MINI) Current alcohol-l dependence, as determined by the MINI.
- Self-reported use of cocaine or amphetamines "daily" or "almost daily" using the relevant questions from the Alcohol, Smoking, and Substance Involvement Screening Test (ASSIST)
- TBI requiring hospitalization that has occurred within 6 months prior to enrollment
- Involvement in one-to-one counseling or psychotherapy targeted to emotional health issues
- Involvement in another treatment trial that may affect participation or outcomes
- Evidence of severe, intractable anger as indicated by history of violence-related crimes, e.g., charges for assault.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (3)
Craig Hospital
Englewood, Colorado, 80237, United States
Data Cordinating Center
Englewood, Colorado, 80237, United States
Moss Rehabilitation Research Institue
Elkins Park, Pennsylvania, 19027, United States
Related Publications (2)
Hart T, Vaccaro MJ, Hays C, Maiuro RD. Anger self-management training for people with traumatic brain injury: a preliminary investigation. J Head Trauma Rehabil. 2012 Mar-Apr;27(2):113-22. doi: 10.1097/HTR.0b013e31820e686c.
PMID: 21407088BACKGROUNDHart T, Brockway JA, Maiuro RD, Vaccaro M, Fann JR, Mellick D, Harrison-Felix C, Barber J, Temkin N. Anger Self-Management Training for Chronic Moderate to Severe Traumatic Brain Injury: Results of a Randomized Controlled Trial. J Head Trauma Rehabil. 2017 Sep/Oct;32(5):319-331. doi: 10.1097/HTR.0000000000000316.
PMID: 28520666RESULT
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Limitations and Caveats
All participants had self-reported problems with anger and were excluded for serious limitations in communication. Thus, the study cannot be generalized to those with very severe cognitive or communication deficits or who deny anger problems.
Results Point of Contact
- Title
- Dr. Tessa Hart, PhD
- Organization
- Moss Rehabilitation Research Institute
Study Officials
- PRINCIPAL INVESTIGATOR
Tessa Hart, PhD
Moss Rehabilitation Research Institute
Publication Agreements
- PI is Sponsor Employee
- No
- Restrictive Agreement
- No
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Institute Scientist, MRRI
Study Record Dates
First Submitted
December 6, 2012
First Posted
December 10, 2012
Study Start
September 1, 2012
Primary Completion
June 1, 2016
Study Completion
September 1, 2016
Last Updated
October 19, 2018
Results First Posted
October 19, 2018
Record last verified: 2018-10